Mimetic Medicines
About Mimetic Medicines
The startup develops lipidated peptidomimetics (SLIPs) that disrupt the bond between Magi2 and perisynaptic N-methyl-D-aspartate receptors (NMDARs) to provide long-lasting analgesia without motor deficits. This technology targets pain management for conditions such as depression, dementia, and stroke, offering an alternative to opioid-based treatments.
What does Mimetic Medicines do?
The startup develops lipidated peptidomimetics (SLIPs) that disrupt the bond between Magi2 and perisynaptic N-methyl-D-aspartate receptors (NMDARs) to provide long-lasting analgesia without motor deficits. This technology targets pain management for conditions such as depression, dementia, and stroke, offering an alternative to opioid-based treatments.
Where is Mimetic Medicines located?
Mimetic Medicines is based in Miami, United States.
When was Mimetic Medicines founded?
Mimetic Medicines was founded in 2023.
- Location
- Miami, United States
- Founded
- 2023
- Employees
- 4 employees